Acrux Limited (ASX:ACR) Eli Lilly provides feedback on initial uptake of Axiron (ASX:ACR) 01 Jul, 2011 01:00 PM ELI LILLY PROVIDES FEEDBACK ON INITIAL UPTAKE OF AXIRON® IN TESTOSTERONE THERAPY MARKET Acrux’s licensee Eli Lilly and Company has provided feedback on the initial sales of Axiron d...read more
Acrux Limited (ASX:ACR) Acrux receives marketing approval for Ellavie in Sweden (ASX:ACR) 27 May, 2011 09:55 AM Today Acrux Limited (ASX : ACR) announced that the Medical Products Agency (MPA) in Sweden has granted a marketing authorisation for Ellavie.
Acrux Limited (ASX:ACR) Positive European opinion for first animal health product (ASX:ACR) 10 May, 2011 05:40 PM POSITIVE EUROPEAN OPINION FOR ACRUX’S FIRST ANIMAL HEALTH PRODUCT Melbourne, 10 May 2011: Acrux (ASX: ACR) announced today that the Committee for Medicinal Products for Veterinary Use (...read more
Acrux Limited (ASX:ACR) Axiron Launched by Eli Lilly in the United States (ASX:ACR) 31 Mar, 2011 11:25 AM Axiron Launched by Eli Lilly in the United States - Axiron® (testosterone) topical solution launched by Eli Lilly in the United States - Testosterone therapy market in the United States ...read more
Acrux Limited (ASX: ACR) Acrux Declares First Dividend of 60 cents per share (ASX:ACR) 24 Mar, 2011 10:40 AM Acrux Declares First Dividend of 60 Cents per Share Highlights: - Unfranked dividend of 60 cents per share, exempt from tax - Record date 6 April 2011, Ex-div date 31 March 2011 - Expected...read more
Acrux Limited (ASX:ACR) Acrux Files Half Year Results (ASX:ACR) 24 Feb, 2011 10:45 AM Acrux Reports Half Year Profit of $56.7 million Highlights: - Profit after tax $56.7 million (2009: loss $2.1 million) - Diluted earnings per share 34 cents (2009: loss 1 cent) - Cash rese...read more